Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Fengchang Bao"'
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0256995 (2021)
Acute myeloid leukemia (AML) is as a highly aggressive and heterogeneous hematological malignancy. MiR-20a-5p has been reported to function as an oncogene or tumor suppressor in several tumors, but the clinical significance and regulatory mechanisms
Externí odkaz:
https://doaj.org/article/0c417fb8567e4269b36a5b936c5ea5d7
Publikováno v:
Case Reports in Pediatrics, Vol 2013 (2013)
We present a rare case of cryptococcal lymphadenitis without immunocompromization in a two-and-a-half-year-old child. He was referred to our center with a fifteen-day history of continued fever. Ultrasound and computed tomography (CT) revealed the en
Externí odkaz:
https://doaj.org/article/abdca6bd65594527a9c66e3fa0db100d
Autor:
Yongcheng Ma, Kai Sun, Wanjun Zhang, Xiawan Yang, Honggang Guo, Huixia Cao, Fengchang Bao, Ahmed Haw, Junwei Niu, Yuqing Chen
Publikováno v:
OncoTargets and Therapy. 13:3823-3837
Purpose The aim of this study was to investigate the antitumor effect of chidamide in combination with bortezomib on gastric cancer cell lines. Materials and methods First, the sensitivity and IC50 values of chidamide and bortezomib in several gastri
Autor:
Hong Qiao, Runhong Yu, Pingchong Lei, Fengchang Bao, Wei Chen, Yao Li, Cheng Lian, Fei Xue, Kai Sun, Yanhui Liu, Xiling Lu
Publikováno v:
International Journal of Biological Sciences
Daunorubicin (Dnr) is at the forefront of acute myeloid leukemia (AML) therapy, but drug resistance poses a major threat to treatment success. MicroRNA (miR)-9 has been shown to have a pivotal role in AML development. However, little is known about t
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0256995 (2021)
PLoS ONE
PLoS ONE
Acute myeloid leukemia (AML) is as a highly aggressive and heterogeneous hematological malignancy. MiR-20a-5p has been reported to function as an oncogene or tumor suppressor in several tumors, but the clinical significance and regulatory mechanisms
Autor:
Wanjun, Zhang, Junwei, Niu, Yongcheng, Ma, Xiawan, Yang, Huixia, Cao, Honggang, Guo, Fengchang, Bao, Ahmed, Haw, Yuqing, Chen, Kai, Sun
Publikováno v:
OncoTargets and therapy
Purpose The aim of this study was to investigate the antitumor effect of chidamide in combination with bortezomib on gastric cancer cell lines. Materials and Methods First, the sensitivity and IC50 values of chidamide and bortezomib in several gastri
Autor:
Wei Chen, Xiling Lu, Fengchang Bao, Pingchong Lei, Cheng Lian, Yao Li, Yanhui Liu, Kai Sun, Fei Xue, Runhong Yu, Hong Qiao
Publikováno v:
Journal of cellular biochemistry. 121(1)
In this study, we aimed to study the effect of miR-33b in regulating sensitivity to daunorubicin (DNR) in acute myelocytic leukemia (AML). We used quantitative real-time polymerase chain reaction and Cell Counting Kit-8 assay to detect the level of m
Autor:
Jing Zhou, Jie Tian, Yusong Lin, Fengchang Bao, Hongna Tan, Meiyun Wang, Yaping Wu, Jianzhong Wan
Publikováno v:
The British Journal of Radiology
Objective: To establish a radiomics nomogram by integrating clinical risk factors and radiomics features extracted from digital mammography (MG) images for pre-operative prediction of axillary lymph node (ALN) metastasis in breast cancer. Methods: 21
To describe the clinical, CT and pathological findings of paediatric peripheral primitive neuroectodermal tumours (pPNETs) to enhance the recognition of these rare tumours.The clinical, CT and pathological findings of 18 paediatric patients with pPNE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41701ce865f931f482d676d8fa5574da
https://europepmc.org/articles/PMC4846188/
https://europepmc.org/articles/PMC4846188/
Publikováno v:
British Journal of Radiology; Apr2016, Vol. 89 Issue 1060, p1-10, 10p